1. Integrated Bioinformatics Analysis for Identificating the Therapeutic Targets of Aspirin in Small Cell Lung Cancer
    Liuyun Gong et al, 2018, Journal of Biomedical Informatics CrossRef
  2. Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
    Alvaro Quintanal-Villalonga et al, 2021, Cancer Discovery CrossRef
  3. Forensic short tandem repeat markers alteration in cancerous tissues: a scoping review
    Izzah Syahira Omar et al, 2024, Egyptian Journal of Forensic Sciences CrossRef
  4. Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
    Wei Cao et al, 2019, Oncology Letters CrossRef
  5. Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations
    Tarcisio Fedrizzi et al, 2021, Computational and Structural Biotechnology Journal CrossRef
  6. Cardiac glycosides display selective efficacy for STK11 mutant lung cancer
    Nayoung Kim et al, 2016, Scientific Reports CrossRef
  7. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma
    Bing Liu et al, 2017, Oncotarget CrossRef
  8. Cardamonin Induces Cell Cycle Arrest, Apoptosis and Alters Apoptosis Associated Gene Expression in WEHI-3 Mouse Leukemia Cells
    Nien-Chieh Liao et al, 2019, The American Journal of Chinese Medicine CrossRef
  9. Synthetic lethality in lung cancer and translation to clinical therapies
    Ada W. Y. Leung et al, 2016, Molecular Cancer CrossRef
  10. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes
    Lorena Lazo de la Vega et al, 2020, Modern Pathology CrossRef
  11. Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature
    Jinlin Zhou et al, 2023, Frontiers in Genetics CrossRef
  12. Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report
    Jie Huang et al, 2022, JTO Clinical and Research Reports CrossRef
  13. Synthetic Lethality in Lung Cancer—From the Perspective of Cancer Genomics
    Iwao Shimomura et al, 2019, Medicines CrossRef
  14. Select human cancer mutants of NRMT1 alter its catalytic activity and decrease N‐terminal trimethylation
    Kaitlyn M. Shields et al, 2017, Protein Science CrossRef
  15. The Diagnostic and Therapeutic Potential of the Epigenetic Modifications of Lung Cancer–Related Genes
    Shengqing Li et al, 2019, Current Pharmacology Reports CrossRef
  16. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients
    Peiwei Chai et al, 2021, Experimental Eye Research CrossRef
  17. Analysis of Cross-Association between mRNA Expression and RNAi Efficacy for Predictive Target Discovery in Colon Cancers
    Euna Jeong et al, 2020, Cancers CrossRef
  18. Sinomenine promotes ferroptosis in lung cancer cells by driving P53 gene
    Zhengkai Xiang et al, 2023, Materials Express CrossRef